Research in Yokohama
Science Explorer records 1 research institutions in Yokohama. The highest-ranked on research quality in 2022–2025 are Kanagawa Cancer Center.
- Research institutions
- 1 1 of them ranked worldwide
- Research works
- 1k ▲ 22% vs 2013–17
- Top-10% rate, 2022–2025
- 15.4% record average 16.5%
A city carries no overall standing here. The composite score is built for institutions and countries, the units its floors and field normalisation were designed around. An empty rank on this page is a statement about the measure, not about the place.
Which research institutions are in Yokohama?
| # | Institution | Works | Against the largest here | World rank |
|---|---|---|---|---|
| 1 | Kanagawa Cancer CenterHospital / health system | 1,025 | #14,027 |
By fractional works over the whole record; world rank on research quality in 2022–2025. Bars are scaled to the largest institution in this city, not to anything off the page.
What is Yokohama strongest at in research?
Relative to its size, research in Yokohama is most concentrated in Oncology and Pulmonary and Respiratory Medicine (19.5× the world share in Oncology).
- OncologySubfield · 50.8 works19×
- Pulmonary and Respiratory MedicineSubfield · 52.7 works15×
Location quotient against the world baseline. Inside a single field a city is a meaningful unit, which is why this is where a city is measured at all.
Which keywords describe research in Yokohama?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Tumor Microenvironment, Targeted Therapy, Immunotherapy, Clinical Practice Guidelines, Clinical Trials, Prognostic Factors and Adjuvant Therapy.
- Surgical Complications
- Pancreatic Cancer
- Immune Checkpoint Blockade
- Immunity
- BRAF Mutation
- Prognostic Markers
- Lung Cancer
- Tumor Staging
- Metastatic Gastric Cancer
- Neoadjuvant Chemotherapy
- EGFR Mutations
- Treatment Guidelines
- Genomic Profiling
- Metastasis
- Survival Analysis
- Cancer
- Adjuvant Therapy
- Clinical Trials
- Immunotherapy
- Tumor Microenvironment
- Chemotherapy
- Targeted Therapy
- Clinical Practice Guidelines
- Prognostic Factors
- Inflammation
- Neoadjuvant Therapy
- Endoscopic Resection
- Molecular Characterization
- Radiotherapy
- ALK Inhibitors
- Gastric Cancer
- Lymph Node Dissection
- Biomarkers
- CT Screening
- Precision Medicine
- Tumor Markers
- Surgical Management
- Preoperative Chemoradiotherapy
- PD-1 and PD-L1
- Gemcitabine
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this city's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy52▲ 32×21 topics
- Tumor Microenvironment25▲ 25×7 topics
- Targeted Therapy25▲ 49×5 topics
- Immunotherapy23▲ 14×16 topics
- Clinical Practice Guidelines22▲ 18×12 topics
- Clinical Trials22▲ 14×7 topics
- Prognostic Factors22▲ 22×12 topics
- Adjuvant Therapy20▲ 69×2 topics
- Inflammation19▲ 4.0×39 topics
- Cancer18▲ 5.7×32 topics
- Neoadjuvant Therapy18▲ 32×5 topics
- Survival Analysis17▲ 26×7 topics
- Endoscopic Resection16▲ 72×2 topics
- Metastasis16▲ 20×11 topics
- Molecular Characterization15▲ 37×5 topics
- Genomic Profiling15▲ 62×2 topics
- Radiotherapy15▲ 17×12 topics
- Treatment Guidelines13▲ 27×3 topics
- ALK Inhibitors13▲ 92×1 topic
- EGFR Mutations13▲ 92×1 topic
- Gastric Cancer12▲ 47×3 topics
- Neoadjuvant Chemotherapy11▲ 59×2 topics
- Lymph Node Dissection11▲ 80×1 topic
- Metastatic Gastric Cancer11▲ 80×1 topic
- Biomarkers10▲ 6.5×13 topics
- Tumor Staging9▲ 36×2 topics
- CT Screening9▲ 59×1 topic
- Lung Cancer9▲ 23×1 topic
- Precision Medicine9▲ 8.4×7 topics
- Prognostic Markers9▲ 36×3 topics
- Tumor Markers9▲ 47×2 topics
- BRAF Mutation8▲ 50×2 topics
- Surgical Management8▲ 8.7×9 topics
- Immunity8▲ 8.6×6 topics
- Preoperative Chemoradiotherapy8▲ 42×2 topics
- Immune Checkpoint Blockade8▲ 30×1 topic
- PD-1 and PD-L18▲ 30×1 topic
- Pancreatic Cancer7▲ 29×3 topics
- Gemcitabine7▲ 44×1 topic
- Surgical Complications7▲ 39×1 topic
What research is done in Yokohama?
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 13 works
- 2 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 11 works
- 3 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 9 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 8 works
- 5 Pancreatic and Hepatic Oncology Research Oncology 7 works
- 6 Lung Cancer Research Studies Oncology 6 works
- 7 Inflammatory Biomarkers in Disease Prognosis Oncology 6 works
- 8 Esophageal Cancer Research and Treatment Surgery 5 works
- 9 Colorectal Cancer Treatments and Studies Oncology 5 works
- 10 Nutrition and Health in Aging Physiology 5 works
Research output over time
The same series as a ribbon — one cell per year, darker for more.